Key facts
- It has raised $2.8M; the latest was Accelerator/Incubator ($1.1M) in Jul 2025.
- Notable investors include Tech Incubator Program for Startup, Mashup Ventures, Murex Partners, Big Basin Capital, Digital Healthcare Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Purple AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Purple AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Purple AI
Developer of a brain disease diagnostic system designed to enhance stroke detection. The company utilizes artificial intelligence to deliver accurate diagnoses, faster processing, advanced image analysis, and risk assessment, enabling medical professionals to improve diagnostic precision and shorten treatment time.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2024
- Employees
- 6
- Website
- purple-ai.co/
- Ownership
- Privately Held (backing)
Purple AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Purple AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Purple AI in its N-PORT filings yet. We sweep new filings monthly.